Setting technology standards to make it easier for HCPs to work with the life sciences industry

Align Biopharma is a life sciences industry standards group, established to make it easier for healthcare professionals (HCPs) to work with life sciences. Through open technology standards, industry can streamline how HCPs get the treatment information they need to deliver improved care to patients.

Technology Standards in Development

Identity Management

Align Biopharma has defined an identification and authentication standard to enable single sign-on for HCPs to access online content – including websites, portals, virtual events, or webinars – across all companies.
View the Draft Version 1.0

Consent and Communication Preferences

Align Biopharma will define standards for consent and preference management so that there is consistency in how HCPs specify communication preferences with each company.

Members

Life Sciences

Allergan • AstraZeneca • Bayer • Biogen • GSK • Janssen
Lilly • Merck KGaA Darmstadt, Germany • Merck & Co., Inc.
Novartis • Pfizer • Shire • Takeda

Allergan • AstraZeneca • Bayer
Biogen • GSK • Janssen • Lilly
Merck KGaA Darmstadt, Germany
Merck & Co., Inc.• Novartis
Pfizer • Shire • Takeda

Technology

Adobe • Exostar • Gigya
Janrain • Okta • Veeva

Services

Accenture • Cognizant
Deloitte • HCL • Mavens

Key Milestones

Summer
2017

Final Identity Management
Standard published

Mid/Late
2017

Consent and Communication
Preferences Standard version 1.0
available for feedback

News

Industry Standards Group, Align Biopharma, Expands to 23 Members
Leading companies join forces to develop and implement new technology standards.
Learn More ››